Back to
BANK OF AMERICA CORP /DE/
FUSN5 quarters
Position history for
BANK OF AMERICA CORP /DE/'s holdings in FUSION PHARMACEUTICALS INC
As of its Q1 2024 13F, Bank of America held 71,496 shares of FUSN (Fusion Pharmaceuticals), worth $1.5M. Bank of America's 13F filings listed FUSN from Q2 2023 to Q1 2024, 4 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$10,858
Total Shares Change
-2,325
Quarter-by-Quarter History
Other major holders of FUSN: FEDERATED HERMES, INC., FIL Ltd, Pentwater Capital Management LP, CANADA PENSION PLAN INVESTMENT BOARD